<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03451708</url>
  </required_header>
  <id_info>
    <org_study_id>2016P000396</org_study_id>
    <nct_id>NCT03451708</nct_id>
  </id_info>
  <brief_title>OKS for the Treatment of Hemispatial Neglect</brief_title>
  <official_title>Optokinetic Stimulation for the Treatment of Hemispatial Neglect - Safety and Efficacy Studies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hemispatial neglect is a disorder where the patient has difficulty attending to objects and
      information in the left side of space, which occurs following strokes to the right side of
      the brain. This project is designed to help us understand how optokinetic stimulation treats
      the symptoms of hemispatial neglect.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Enrollment and other trial activities have temporarily paused due to COVID-19 and are expected
    to resume in the future; This is not a suspension of IRB approval
  </why_stopped>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patient blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Hemispatial neglect scores</measure>
    <time_frame>After 1 hour of OKS</time_frame>
    <description>Performance on Center of Cancellation Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Hemispatial neglect scores</measure>
    <time_frame>After 1 hour of OKS</time_frame>
    <description>Performance on Behavioral Inattention Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of OKS on vision</measure>
    <time_frame>After 1 hour of OKS</time_frame>
    <description>visual acuity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of OKS on vision</measure>
    <time_frame>After 1 hour of OKS</time_frame>
    <description>reading speed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in secondary hemispatial neglect scores</measure>
    <time_frame>After 1 hour of OKS</time_frame>
    <description>Line bisection score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in secondary hemispatial neglect scores</measure>
    <time_frame>After 1 hour of OKS</time_frame>
    <description>grip strength</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in secondary hemispatial neglect scores</measure>
    <time_frame>After 1 hour of OKS</time_frame>
    <description>extinction score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of OKS on gait</measure>
    <time_frame>After 1 hour of OKS</time_frame>
    <description>Gait assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of OKS on gait</measure>
    <time_frame>After 1 hour of OKS</time_frame>
    <description>Balance assessments</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Neglect, Hemispatial</condition>
  <condition>Neglect, Sensory</condition>
  <condition>Neglect, Hemisensory</condition>
  <arm_group>
    <arm_group_label>Optimization of OKS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Crossover study examining various OKS protocols on improving symptoms of hemispatial neglect</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Safety and efficacy study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Randomized study assessing the safety and efficacy of OKS in treating hemispatial neglect</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Effect of repetitive stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Benefits of daily, repetitive OKS in treating hemispatial neglect</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OKS and gait</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Effect of OKS on gait and balance</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OKS</intervention_name>
    <description>Optokinetic stimulation will be displayed on a see-through liquid crystal display lens placed in front of the subjects.</description>
    <arm_group_label>Effect of repetitive stimulation</arm_group_label>
    <arm_group_label>OKS and gait</arm_group_label>
    <arm_group_label>Optimization of OKS</arm_group_label>
    <arm_group_label>Safety and efficacy study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with right hemispheric lesions resulting in hemispatial neglect as confirmed
             by Behavioral Inattention Test or Center of Cancellation Test

        Exclusion Criteria:

          -  Reduced vision

          -  Documented vestibular disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chun Lim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 8, 2018</study_first_submitted>
  <study_first_submitted_qc>February 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2018</study_first_posted>
  <last_update_submitted>April 24, 2020</last_update_submitted>
  <last_update_submitted_qc>April 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Perceptual Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

